PRCT
HealthcarePROCEPT BioRobotics Corporation
$27.18+1.06 (+4.06%)
Prev Close
$26.12
Open
$26.12
High
$27.39
Low
$26.00
Volume
1.00M
Market Cap
$1.43B
P/E
—
Div Yield
—
PRCT Price Chart
PRCT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026↗ | Nouri Alaleh | officer: EVP, CLO, CORP. SEC. | Sell | 3,243 | $25.65 | $83.2K | 111,166 |
| Mar 9, 2026↗ | Desai Antal Rohit | director | Buy | 426,262 | $24.59 | $10.48M | 426,262 |
| Mar 9, 2026↗ | Nouri Alaleh | officer: EVP, CLO, CORP. SEC. | Sell | 6,892 | $23.70 | $163.4K | 114,264 |
| Mar 9, 2026↗ | Waters Kevin | officer: EVP, CFO | Sell | 6,721 | $23.70 | $159.3K | 152,264 |
| Aug 13, 2025↗ | MOLL FREDERIC H | Director | Buy | 20,000 | $39.26 | $785.1K | 0 |
| Jun 10, 2025↗ | Desai Antal Rohit | Director | Sell | 75,000 | $62.93 | $4.72M | 0 |
| Jun 6, 2025↗ | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 20,000 | $64.13 | $1.28M | 0 |
| Jun 3, 2025↗ | Desai Antal Rohit | Director | Sell | 75,000 | $62.16 | $4.66M | 0 |
| Mar 18, 2025↗ | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 316 | $57.06 | $18.0K | 0 |
| Mar 18, 2025↗ | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 247 | $57.06 | $14.1K | 0 |
| Mar 18, 2025↗ | Waters Kevin | EVP, CFO | Sell | 733 | $57.06 | $41.8K | 0 |
| Mar 18, 2025↗ | Zadno Reza | President, CEO | Sell | 5,475 | $57.06 | $312.4K | 0 |
| Mar 6, 2025↗ | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 3,641 | $61.31 | $223.2K | 0 |
| Mar 6, 2025↗ | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 3,588 | $61.31 | $220.0K | 0 |
| Mar 6, 2025↗ | Waters Kevin | EVP, CFO | Sell | 3,662 | $61.31 | $224.5K | 0 |
| Mar 6, 2025↗ | Zadno Reza | President, CEO | Sell | 15,916 | $61.31 | $975.8K | 0 |
PRCT Insider Buying Activity
The following table shows recent insider purchases of PROCEPT BioRobotics Corporation (PRCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026↗ | Desai Antal Rohit | director | Buy | 426,262 | $24.59 | $10.48M | 426,262 |
| Aug 13, 2025↗ | MOLL FREDERIC H | Director | Buy | 20,000 | $39.26 | $785.1K | 0 |
PRCT Insider Selling Activity
The following table shows recent insider sales of PROCEPT BioRobotics Corporation (PRCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026↗ | Nouri Alaleh | officer: EVP, CLO, CORP. SEC. | Sell | 3,243 | $25.65 | $83.2K | 111,166 |
| Mar 9, 2026↗ | Nouri Alaleh | officer: EVP, CLO, CORP. SEC. | Sell | 6,892 | $23.70 | $163.4K | 114,264 |
| Mar 9, 2026↗ | Waters Kevin | officer: EVP, CFO | Sell | 6,721 | $23.70 | $159.3K | 152,264 |
| Jun 10, 2025↗ | Desai Antal Rohit | Director | Sell | 75,000 | $62.93 | $4.72M | 0 |
| Jun 6, 2025↗ | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 20,000 | $64.13 | $1.28M | 0 |
| Jun 3, 2025↗ | Desai Antal Rohit | Director | Sell | 75,000 | $62.16 | $4.66M | 0 |
| Mar 18, 2025↗ | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 316 | $57.06 | $18.0K | 0 |
| Mar 18, 2025↗ | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 247 | $57.06 | $14.1K | 0 |
| Mar 18, 2025↗ | Waters Kevin | EVP, CFO | Sell | 733 | $57.06 | $41.8K | 0 |
| Mar 18, 2025↗ | Zadno Reza | President, CEO | Sell | 5,475 | $57.06 | $312.4K | 0 |
| Mar 6, 2025↗ | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 3,641 | $61.31 | $223.2K | 0 |
| Mar 6, 2025↗ | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 3,588 | $61.31 | $220.0K | 0 |
| Mar 6, 2025↗ | Waters Kevin | EVP, CFO | Sell | 3,662 | $61.31 | $224.5K | 0 |
| Mar 6, 2025↗ | Zadno Reza | President, CEO | Sell | 15,916 | $61.31 | $975.8K | 0 |
PRCT Insiders
Similar Stocks to PRCT
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
MDT
Medtronic plc
$87.06-0.37%
$112.19B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.31+0.77%
$19.73B